Paradigm Biocapital Advisors LP
Source: SEC Form 13F · as of Mar 2026Paradigm Biocapital Advisors LP holds 14 biotech & pharma companies tracked by BioSniper, totaling $1.71B in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$1.71B
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 5,774,016 | $663.0M |
| INSMINSMED Inc | 1,254,488 | $205.1M |
| CNTACentessa Pharmaceuticals plc | 3,574,048 | $142.0M |
| TERNTerns Pharmaceuticals, Inc. | 2,216,499 | $116.9M |
| APGEApogee Therapeutics, Inc. | 1,348,243 | $113.5M |
| CYTKCYTOKINETICS INC | 1,480,857 | $97.6M |
| ABVXAbivax SA | 772,473 | $86.0M |
| TNGXTango Therapeutics, Inc. | 4,009,679 | $83.9M |
| SRRKScholar Rock Holding Corp | 1,226,080 | $60.3M |
| MIRMMirum Pharmaceuticals, Inc. | 625,000 | $57.7M |
| MANEVeradermics Incorporated | 525,000 | $33.2M |
| GPCRStructure Therapeutics Inc. | 545,287 | $26.3M |
| ORICOric Pharmaceuticals, Inc. | 1,701,217 | $21.6M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 868,213 | $7.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.